Loading
Making PSMA, FDG, and new tracers under drug-manufacturing rules and delivering them daily.
FDA-approved PET drugs are made under cGMP at commercial radiopharmacies (PETNET, Cardinal Health, SOFIE, Jubilant, Curium) or academic sites under ANDA/NDA. New tracers (PSMA agents from Lantheus, Telix, Novartis; FES; FAPI in trials) rely on these networks for launch reach. Kits (Illuccix, Locametz) versus centrally produced doses (Pylarify) is a business-model divide.
Automated radiosynthesis modules, cassette-based chemistry, and rapid QC (radiochemical purity, endotoxin) before release.
Dependencies are what this technology cannot be delivered without: manufacturing steps, instruments, software, upstream methods. See its full chain on the map.
Query for this technology: (TITLE:"PET tracer manufacturing and distribution" OR ABSTRACT:"PET tracer manufacturing and distribution") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about PET tracer manufacturing and distribution, not a curated reading list.
Shares Radionuclide generators and cold kits, Radiopharmacy and cyclotron networks, Cyclotron isotope production (F-18, Ga-68, Cu-64, Zr-89, At-211) and the tag supporting.
Shares Isotopia Molecular Imaging, Radiopharmacy and cyclotron networks, Radiopharmaceutical GMP and releasing a drug that decays and the tag supporting.
Shares Medical cyclotrons, hot cells, and synthesis modules and the tag supporting.
Shares Medical cyclotrons, hot cells, and synthesis modules and the tag supporting.
Shares CT, MRI and PET scanner manufacturing and the tag supporting.
Shares Cardinal Health Nuclear & Precision Health Solutions and the tag supporting.
Shares CT, MRI and PET scanner manufacturing and the tag supporting.
Shares CT, MRI and PET scanner manufacturing and the tag supporting.